NORLANDIA HEALTH & CARE GROUP AS financials
NORLANDIA HEALTH & CARE GROUP AS
Country: NO Reporting currency: NOK Latest annual report: 2024-12-31
LEI:
549300FBOBWU7L8EH481 Financial statements
(NOK, as reported — unscaled; 99 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | NOK 11.70B | NOK 10.70B |
| Other income | NOK 80.4M | NOK 75.7M |
| Employee benefits expense | NOK 8.44B | NOK 7.64B |
| Raw materials & consumables used | NOK 459.7M | NOK 351.2M |
| Depreciation & amortisation | NOK 1.06B | NOK 932.1M |
| Operating profit (EBIT) | NOK 515.0M | NOK 434.2M |
| Net finance income / (cost) | -NOK 568.6M | -NOK 482.0M |
| Finance costs | NOK 587.1M | NOK 486.3M |
| Profit before tax | -NOK 55.2M | -NOK 47.0M |
| Income tax expense | -NOK 19.0M | -NOK 12.5M |
| Profit for the year | -NOK 36.2M | -NOK 34.5M |
| — attributable to owners | -NOK 27.9M | -NOK 39.0M |
| — attributable to NCI | -NOK 8.3M | NOK 4.5M |
| Total comprehensive income | -NOK 29.4M | NOK 17.7M |
| Cash flow statement | ||
| Cash generated from operations | NOK 1.58B | NOK 1.35B |
| Net cash from operating activities | NOK 1.57B | NOK 1.31B |
| Net cash from investing activities | -NOK 225.8M | -NOK 98.4M |
| Purchase of PP&E (capex) | NOK 327.9M | NOK 244.3M |
| Net cash from financing activities | -NOK 1.25B | -NOK 1.15B |
| Dividends paid | NOK 45.0M | NOK 0 |
| Proceeds from borrowings | NOK 105.1M | NOK 34.1M |
| Lease liability payments | NOK 855.3M | NOK 724.0M |
| Net change in cash | NOK 94.3M | NOK 60.0M |
| Balance sheet | ||
| Total assets | NOK 13.71B | NOK 13.13B |
| Non-current assets | NOK 12.18B | NOK 11.50B |
| Property, plant & equipment | NOK 983.9M | NOK 957.9M |
| Intangible assets & goodwill | NOK 3.22B | NOK 3.18B |
| Inventories | NOK 8.4M | NOK 7.7M |
| Trade & other receivables | NOK 683.2M | NOK 746.8M |
| Cash & equivalents | NOK 440.2M | NOK 346.0M |
| Total equity | NOK 899.7M | NOK 943.5M |
| — attributable to owners | NOK 910.6M | NOK 944.7M |
| Non-controlling interests | -NOK 11.0M | -NOK 1.2M |
| Non-current liabilities | NOK 9.73B | NOK 9.28B |
| Lease liabilities (non-current) | NOK 6.73B | NOK 6.30B |
| Current liabilities | NOK 3.08B | NOK 2.91B |
| Lease liabilities (current) | NOK 908.1M | NOK 764.1M |
| Trade & other payables | NOK 245.0M | NOK 347.0M |
| Deferred tax liabilities | NOK 179.9M | NOK 218.3M |
| Derived metrics | ||
| Free cash flow | NOK 1.24B | NOK 1.07B |
| Operating margin | 4.4% | 4.1% |
| Net margin | -0.3% | -0.3% |
| Return on equity | -4.0% | -3.7% |
| Cash conversion ratio | -43.38× | -38.01× |
| Capex coverage | 4.79× | 5.37× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -NOK 648.0K | -NOK 2.2M |
| Adjustments For Decrease Increase In Trade Account Receivable | NOK 106.2M | -NOK 212.2M |
| Adjustments For Depreciation and Amortisation Expense | NOK 1.06B | NOK 932.1M |
| Adjustments For Finance Costs | NOK 568.6M | NOK 482.0M |
| Adjustments For Increase Decrease In Other Operating Payables | -NOK 32.2M | NOK 260.7M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -NOK 80.4M | -NOK 74.7M |
| Adjustments For Provisions | NOK 7.7M | NOK 8.4M |
| Adjustments For Undistributed Profits of Associates | -NOK 1.6M | NOK 806.0K |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | NOK 4.8M | -NOK 19.3M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | NOK 59.9M | -NOK 62.7M |
| Comprehensive Income Attributable To Noncontrolling Interests | -NOK 11.9M | -NOK 1.8M |
| Comprehensive Income Attributable To Owners of Parent | -NOK 17.5M | NOK 19.5M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | NOK 1.52B | NOK 1.63B |
| Current Tax Liabilities Current | NOK 5.1M | NOK 11.8M |
| Deferred Tax Assets | NOK 231.8M | NOK 225.0M |
| Dividends Recognised As Distributions To Noncontrolling Interests | -NOK 153.0K | -NOK 144.0K |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -NOK 96.0K | NOK 14.2M |
| Equity and Liabilities | NOK 13.71B | NOK 13.13B |
| Finance Income | NOK 11.6M | NOK 11.3M |
| Gains Losses On Exchange Differences On Translation Before Tax | NOK 11.3M | NOK 44.6M |
| Income Tax Relating To Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss | -NOK 1.3M | NOK 3.0M |
| Income Taxes Paid Refund Classified As Operating Activities | NOK 6.7M | NOK 33.2M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | NOK 925.0K | NOK 541.0K |
| Increase Decrease Through Other Distributions To Owners | — | NOK 10.0M |
| Increase Decrease Through Transfers and Other Changes Equity | NOK 7.3M | -NOK 74.2M |
| Intangible Assets Other Than Goodwill | NOK 503.7M | NOK 522.7M |
| Interest Paid Classified As Financing Activities | NOK 548.3M | NOK 462.4M |
| Interest Received Classified As Investing Activities | NOK 6.9M | NOK 11.6M |
| Investment Accounted For Using Equity Method | NOK 76.6M | NOK 34.5M |
| Issue of Equity | — | NOK 388.5M |
| Issued Capital | NOK 496.1M | NOK 496.1M |
| Liabilities | NOK 12.81B | NOK 12.19B |
| Noncurrent Provisions For Employee Benefits | NOK 3.5M | NOK 1.4M |
| Noncurrent Receivables | NOK 111.0M | NOK 17.7M |
| Other Cash Payments To Acquire Interests In Joint Ventures Classified As Investing Activities | NOK 10.8M | NOK 8.0M |
| Other Comprehensive Income | NOK 6.8M | NOK 52.2M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -NOK 5.7M | NOK 10.6M |
| Other Current Financial Liabilities | NOK 455.1M | NOK 381.6M |
| Other Current Nonfinancial Liabilities | NOK 1.47B | NOK 1.41B |
| Other Expense By Nature | NOK 1.31B | NOK 1.41B |
| Other Finance Income Cost | NOK 6.9M | -NOK 7.0M |
| Other Noncurrent Financial Assets | NOK 33.0M | NOK 21.3M |
| Other Noncurrent Financial Liabilities | NOK 2.69B | NOK 2.62B |
| Other Noncurrent Nonfinancial Liabilities | NOK 125.2M | NOK 142.1M |
| Other Receivables | NOK 391.4M | NOK 530.4M |
| Payments of Other Equity Instruments | NOK 2.24B | NOK 657.0M |
| Proceeds From Current Borrowings | NOK 103.1M | NOK 298.2M |
| Proceeds From Issuing Other Equity Instruments | NOK 2.28B | NOK 501.4M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | NOK 170.7M | NOK 60.3M |
| Repayments of Noncurrent Borrowings | NOK 49.9M | NOK 144.9M |
| Retained Earnings | NOK 414.6M | NOK 448.6M |
| Revenue and Operating Income | NOK 11.78B | NOK 10.77B |
| Rightofuse Assets That Do Not Meet Definition of Investment Property | NOK 7.03B | NOK 6.55B |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -NOK 1.6M | NOK 806.0K |
Methodology
Every line item above is a fact tagged in NORLANDIA HEALTH & CARE GROUP AS's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (NOK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.